×

Botulinum toxin treatment of anxiety and bipolar disorders

  • US 9,238,061 B2
  • Filed: 11/21/2013
  • Issued: 01/19/2016
  • Est. Priority Date: 10/29/2003
  • Status: Expired due to Fees
First Claim
Patent Images

1. A method for treating an anxiety disorder in a patient in need thereof, comprising directly administering a botulinum toxin to a trigeminal nerve of the patient, thereby treating the anxiety disorder.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×